Chemours is trading $15.45 (+4.39%) with no verified August 11 company-specific after-hours announcement or late-breaking catalyst identified.

  • It closed at $14.80 after the August 11, 2026 regular session.
  • Recent coverage focused on the second-quarter earnings miss, weaker volumes, cautious outlook, and Morgan Stanley’s August 10 price-target reduction to $18.
  • The broader market was lower, so market sentiment does not clearly explain the upward move.